|
CYRX | Cryoport, Inc. |
|
|
CYRX | Cryoport, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.23 |
| Leverage | 40.35% |
| Market Cap | $ 339.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -157.3m |
| Margin | -69.76% |
Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.